We discuss reduced dose apixaban for months 6+ of treating cancer-associated VTE (API-CAT) and the impact (or lack thereof) of pausing BTK-inhibitors around vaccination (IMPROVE)
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
